Signal from the log
Retro Biosciences
United States · Biotech
Société californienne qui développe des thérapies géniques et de remplacement cellulaire avec l'objectif affiché d'ajouter dix années de vie en bonne santé. Elle a engagé un essai clinique sur un traitement oral visant les agrégats de protéines de la maladie d'Alzheimer. Attention, le chiffre de 1,8 milliard de dollars est une VALORISATION : le montant du tour n'a pas été communiqué.
Spotted Amount read from the headline
Announced on , logged by the watch of 17 August 2026.
- Operation
- Funding round
- Country
- United States
- Sector
- Biotech
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
The investors
With Sam Altman
What is missing before publishing
- No public amount. A missing amount is never estimated or inferred from a filing.
- The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Source longevity
Logged on 17 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification The fields shown come from an automatic reading of the source headline. They have not yet been checked against the press release and should not be quoted as verified.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.